[Federal Register Volume 81, Number 92 (Thursday, May 12, 2016)]
[Notices]
[Pages 29568-29569]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-11243]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services is hereby giving notice that 
the National Vaccine Advisory Committee (NVAC) will hold a meeting June 
7-8, 2016. The meeting is open to the public. However, pre-registration 
is required for both public attendance and public comment. Individuals 
who wish to attend the meeting and/or participate in the public comment 
session should register at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings. Participants may also register by emailing 
[email protected] or by calling (202) 690-5566 and providing their name, 
organization, and email address.

DATES: The meeting will be held on June 7-8, 2016. The meeting times 
and agenda will be posted on the NVAC Web site at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings as soon as they become available.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, the Great Hall, 200 Independence Avenue SW., 
Washington, DC 20201.
    The meeting can also be accessed through a live webcast the day of 
the meeting. For more information, visit http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. 
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: 
(202) 690-5566; email: [email protected].

SUPPLEMENTARY INFORMATION:  Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The NVAC was established to provide advice and 
make recommendations to the Director of the National Vaccine Program on 
matters related to the Program's responsibilities. The Assistant 
Secretary for Health serves as Director of the National Vaccine 
Program.
    The June 2016 NVAC meeting will continue important discussions on 
addressing the barriers and scientific challenges to the development of 
new and improved vaccines, with a presentation from the NVAC Maternal 
Immunization Working Group of their draft recommendations for 
overcoming barriers to research and development of vaccines for use in 
pregnant women. The NVAC will host a comprehensive discussion on the 
financial costs and perceived barriers to providing immunization 
services across the lifespan. Committee discussions will also include 
an update on immunization priorities at the local level, efforts to 
improve immunization coverage among adults and adolescents, and 
findings from a midcourse review of the 2010 National Vaccine Plan on 
the areas of greatest opportunity for strengthening the immunization 
system going forward. Please note that agenda items are subject to 
change as priorities dictate. Information on the final meeting agenda 
will be posted prior to the meeting on the NVAC Web site: http://www.hhs.gov/nvpo/nvac.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend in person and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the National Vaccine Program Office at 
the address/phone listed above at least one week prior to the meeting. 
For those unable to attend in person, a live webcast will be available. 
More information on registration and accessing the webcast can be found 
at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Individuals are also welcome to submit their written 
comments. Written comments should not exceed three pages in length. 
Individuals submitting written comments should email their comments to 
the National Vaccine Program Office ([email protected]) at least five 
business days prior to the meeting.


[[Page 29569]]


    Dated: May 3, 2016.
Bruce Gellin,
Executive Secretary, National Vaccine Advisory Committee, Deputy 
Assistant Secretary for Health, Director, National Vaccine Program 
Office.
[FR Doc. 2016-11243 Filed 5-11-16; 8:45 am]
 BILLING CODE 4150-44-P